FAIRFAX, Va.The Society of Interventional Radiology Foundation's Discovery Campaign, which seeks to further the growth of minimally invasive medicine into new areas of discovery, announced a major corporate pledge to that initiative. Sirtex Medical Inc.a medical devices company that researches, develops and brings to market novel treatments for liver cancer using small particle technology and has its U.S. headquarters in Wilmington, Mass.has pledged $50,000 and is a "Partner in Research" supporter.
"With this commitment of support, Sirtex makes a solid investment in the education and training of the next generation of interventional radiologists," said Gordon McLennan, M.D., FSIR, chair of the SIRF board of directors and an interventional radiologist with the Cleveland Clinic in Cleveland, Ohio. He added that funding will be used to support grants, research consensus panels, registries, studies addressing comparative effectiveness, clinical trials and educational programming. "One of the major priorities of the SIR Foundation is to increase support for cutting-edge research. We thank Sirtex Medical for coming forward to support us on this venture," he noted.
"Sirtex Medical is proud to continue our long-standing relationship with SIR through this pledge to the SIR Foundation," said Michael Mangano, the company's president. "We are committed to the ongoing education and training of interventional radiologists to ensure that the high level of quality that this important discipline is renowned for can continue," he added.
|Contact: Ellen Acconcia|
Society of Interventional Radiology